Paracetamol Aurovitas

Paracetamol, the active ingredient in Paracetamol Aurovitas, is an analgesic presented as an oral tablet for oral use. It provides pain relief and reduces fever in adults and children when used according to professional guidance.

GNH USA supplies Paracetamol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol Aurovitas acts within the prostaglandin pathway to alleviate pain and lower body temperature.

- Pain relief: reduces mild to moderate pain such as headache, toothache, or musculoskeletal discomfort. - Fever reduction: lowers elevated body temperature associated with infections or inflammatory conditions. - Post‑operative discomfort: helps manage short‑term pain after minor surgical procedures.

Paracetamol Aurovitas is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset that usually resolves without intervention. - Abdominal discomfort: transient pain or fullness in the upper abdomen. - Rash or mild skin irritation: occasional erythematous patches. - Headache: paradoxical headache in a small proportion of users. - Elevated liver enzymes: transient laboratory changes without clinical symptoms.

Serious or Rare Side Effects: - Severe hepatic injury: potentially life‑threatening liver failure, especially with overdose. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare severe skin reactions. - Blood dyscrasias: aplastic anemia or agranulocytosis in extremely rare cases. - Hypersensitivity anaphylaxis: acute allergic reaction requiring immediate medical care. - Renal impairment: rare cases of acute kidney injury with prolonged high‑dose use.

Paracetamol Aurovitas should be used with awareness of specific safety considerations.

- Dose limitation: do not exceed the maximum daily amount recommended by a healthcare professional. - Liver disease: avoid or use only under strict medical supervision in patients with hepatic impairment. - Alcohol consumption: limit intake, as concurrent use increases risk of liver toxicity. - Concomitant medications: review all other products containing paracetamol to prevent accidental overdose. - Pregnancy and breastfeeding: consult a physician before use; safety data are limited. - Store at ambient temperature: keep below 25 °C, retain in the original packaging, and protect from moisture and direct sunlight.

Paracetamol Aurovitas may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: combined use markedly raises risk of hepatic injury. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Carbamazepine, phenytoin, or rifampicin: potent hepatic enzyme inducers that can reduce paracetamol efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may slightly increase plasma concentrations of estrogen components. - Antihypertensives (e.g., ACE inhibitors): monitor blood pressure as paracetamol can affect renal prostaglandin balance. - Antiepileptic drugs (e.g., valproate): may alter liver enzyme activity, requiring periodic liver function tests.